Clinical Trials Sponsored by ADM Korea Inc

Total 165 results

VTBIO Co. LTD
ADM Korea Inc

Completed

Study to Explore the Optimal Dosage/Administration in Alzheimer's Disease (ADD)

Alzheimer's Disease

Korea, Republic of
ADMA Biologics, Inc.

Recruiting

An Open Label, Multicenter Study to Evaluate the Pharmacokinetics, Efficacy and Safety of ASCENIV™ (IGIV) in Pediatric Subjects With Primary Immunodeficiency Diseases (PIDD)

Primary Immune Deficiency

United States
ADMA Biologics, Inc.

Terminated

Randomized Phase II Study of Hepatitis C Immune Globulin Intravenous (Human), Civacir(TM), in Liver Transplantation

Transplantation Infection | Evidence of Liver Transplantation | Sequelae of Viral Hepatitis

United States
AIM Therapeutics Inc.

Completed

Efficacy, Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Oral Administration of AIM-102 in Patients With Mild to Moderate Allergic Asthma

Asthma

Canada
AIM ImmunoTech Inc.

Terminated

A Randomized, Dose-ranging Study of Alferon LDO in Asymptomatic HIV+ Subjects

HIV Infections

United States
AIM ImmunoTech Inc.

Terminated

Safety and Efficacy of Ampligen in the Treatment of HIV Patients Failing HAART

HIV Infection | HIV Seropositivity

United States
AIM ImmunoTech Inc.

Available

Ampligen in Chronic Fatigue Syndrome

Chronic Fatigue Syndrome

United States
AVM Biotechnology Inc

Available

Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients

Cancer | Breast Cancer | Glioblastoma | Gastric Cancer | Pancreatic Cancer | Hodgkin Lymphoma | Ovarian Cancer | Prostate Cancer | Acute Leukemia | Non-hodgkin Lymphoma | Squamous Cell Carcinoma | Tumor, Solid | Tumor, Brain | Spindle Cell Sarcoma
ADMA Biologics, Inc.

Completed

Study to Evaluate Safety and Pharmacokinetics of BIVIGAM® in Primary Immune Deficiency Subjects Aged 2 to 16

Humoral Immune Response

United States
ADMA Biologics, Inc.

Active, not recruiting

A Study About Low Blood Pressure in Patients With Primary Immunodeficiency Disease Treated With Immune Globulin Products

Primary Immune Deficiency Disorder

United States
ADMA Biologics, Inc.

Completed

Open Label, Phase III Study of NABI-IGIV 10% [Immune Globulin Intravenous(Human), 10%] In Subjects With Primary Immune Deficiency Disorders (PIDD)

Primary Immune Deficiency Disorders (PIDD)

United States
AUM Cardiovascular, Inc.

Completed

Clinical Evaluation of the CADence Device in Detection of Coronary Artery Diseases (TURBULENCE)

Coronary Artery Disease

United States
ADMA Biologics, Inc.

Completed

Pharmacokinetics, Efficacy, and Safety Study of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)

Primary Immune Deficiency Disorder

United States
ADMA Biologics, Inc.

Completed

RI-001 in Immunosuppressed Respiratory Syncytial Virus (RSV) Infected Patients at Risk of Lower Tract RSV Illness

Lower Respiratory Tract Infection | Upper Respiratory Tract Infection

United States, Canada
Inocras Korea Inc.

Recruiting

Whole Genome Sequencing in Breast Cancer (WGS SIT)

Breast Cancer

Korea, Republic of
AUM Cardiovascular, Inc.

Completed

Angiographic Comparison in an Observational Study of CADence (The AMBIENCE Study) (AMBIENCE)

Coronary Artery Disease

United States
AUM Cardiovascular, Inc.

Completed

Repeatability and Reproducibility of the CADence™System (SEQUEL)

Coronary Artery Disease

United States
AIM ImmunoTech Inc.

Terminated

Safety Study of FluMist With and Without Ampligen

Influenza, Human

United States
AUM Cardiovascular, Inc.

Withdrawn

Clinical Evaluation of the CADenceTM System in Detection of Coronary Artery Diseases (CADENCE)

Coronary Artery Disease

United States
AIM ImmunoTech Inc.

Completed

The Role of Ampligen in Strategic Therapeutic Intervention (STI) of HAART

HIV Infection | HIV Seropositivity

United States
AIM ImmunoTech Inc.

Completed

The Study of the Safety and Efficacy of Ampligen in Chronic Fatigue Syndrome

Chronic Fatigue Syndrome | Myalgic Encephalomyelitis
AIM ImmunoTech Inc.

Completed

Study of Alferon® LDO (Low Dose Oral) in Normal Volunteers

Severe Acute Respiratory Syndrome

Hong Kong
Earlogic Korea, Inc.

Completed

The Effect of Sound Stimulation on Hearing Ability

Sensorineural Hearing Loss

Korea, Republic of
Earlogic Korea, Inc.

Completed

The Effect of Sound Stimulation on Pure-tone Hearing Threshold

Sensorineural Hearing Loss

United States
AVM Biotechnology Inc
Medpace, Inc.

Not yet recruiting

Evaluating AVM0703 for Treatment of COVID-19 or Influenza-mediated ARDS (AVM0703)

Covid19 | Influenza, Human | ARDS
AVM Biotechnology Inc
Medpace, Inc.

Recruiting

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies (OPAL)

Lymphoid Malignancies

United States
Korea University Guro Hospital
Pharmbio Korea Inc.

Not yet recruiting

Intravenous Iron Infusion on Chemotherapy-induced Anemia

Colon Cancer | Chemotherapeutic-Induced Anemia
Eisai Korea Inc.

Completed

A Study of Lenvatinib in Combination With Pembrolizumab in Korean Patients

Carcinoma | Renal Cell Carcinoma | Endometrial Neoplasms | Endometrium

Korea, Republic of
Eisai Korea Inc.

Completed

A Study of Lenvima (Lenvatinib) in Korean Unresectable Hepatocellular Carcinoma (uHCC) Participants

Carcinoma, Hepatocellular | Liver Neoplasms

Korea, Republic of
Eisai Korea Inc.

Completed

A Study for Tecfidera (Dimethyl Fumarate) Capsules in Korean Participants With Relapsing-Remitting Multiple Sclerosis

Multiple Sclerosis, Relapsing-remitting

Korea, Republic of
Eisai Korea Inc.

Completed

Symbenda Post-Marketing Surveillance (PMS)

Lymphoma, Non-Hodgkin | Multiple Myeloma | Lymphocytic Leukemia

Korea, Republic of
Eisai Korea Inc.

Completed

A Multi-national Study to Identify Treatment Discontinuation Rate in de Novo Alzheimer's Disease Patients Who Have Been Newly Prescribed With Donepezil (Aricept) in Asia (ADOS) (ADOS)

Alzheimer's Disease

China, Taiwan, Korea, Republic of, Singapore, Thailand, Philippines
Eisai Korea Inc.

Completed

A Multicenter Comparative Trial of Zonisamide and Topiramate as Initial Monotherapy in Untreated Epilepsies

Epilepsy

Korea, Republic of
Linical Korea
National Cancer Center, Korea; Astellas Pharma Korea, Inc.

Completed

To Evaluate the Efficacy and Safety of ADVAGRAF® After Treatment With a Tacrolimus in New Liver Transplant Recipients (Assign)

Liver Transplantation
Eisai Korea Inc.

Completed

A Study of Pariet to Prevent Gastric and Duodenal Ulcer Associated With Low-aspirin in Korean Participants With a History of Gastric and Duodenal Ulcer

Duodenal Ulcer | Stomach Ulcer

Korea, Republic of
Eisai Korea Inc.

Completed

Open-label, Multi-center Trial of Zonisamide as Adjunctive Therapy in Patients With Uncontrolled Partial Epilepsy

Epilepsy

Korea, Republic of
Eisai Korea Inc.

Completed

Comparative Study of Zonisamide and Carbamazepine as an Initial Monotherapy: Efficacy and Safety Evaluation

Epilepsy

Korea, Republic of
Eisai Korea Inc.

Completed

Alzheimer's Disease Long-term Follow-up Study (ALF Study)

Alzheimer's Disease

Korea, Republic of
Eisai Korea Inc.

Completed

A Study of Fycompa (Perampanel) in Korean Participants

Epilepsy

Korea, Republic of
Eisai Korea Inc.

Completed

Study in Patients With Moderated to Severe Rheumatoid Arthritis Who Have Failed to Combination Therapy of Conventional Disease-modifying Antirheumatic Drugs (cDMARDs) to cDMARD Plus ANti-TNF Versus cDMARDs in Real World (HUMAN)

Arthritis, Rheumatoid

Korea, Republic of
Eisai Korea Inc.

Completed

Study to Observe the Change in Microbiome in Human Derived Sample and the Relation With Clinical Response Before and After the Anti-TNF Treatment in IBD Patients (ETERNITY)

Inflammatory Bowel Disease

Korea, Republic of
Eisai Korea Inc.

Completed

A Plan on Investigation and Collection of Aricept Safety Information With a Dose Increase on Alzheimer's Disease Patients (AID)

Alzheimer's Disease

Korea, Republic of
Eisai Korea Inc.

Completed

Eribulin Mesylate Phase IV Clinical Trial in Korean Patients With Metastatic or Locally Advanced Breast Cancer (ESKIMO)

Breast Cancer | Breast Neoplasms

Korea, Republic of
Eisai Korea Inc.

Terminated

Correlation Between Regional Brain Volume and Response to Donepezil Treatment in AD Patients

Alzheimer's Disease

Korea, Republic of
Eisai Korea Inc.

Completed

Low and High Dose Zonisamide in Children as Monotherapy

Epilepsy

Korea, Republic of
Eisai Korea Inc.

Recruiting

A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants

Arthritis, Rheumatoid | Colitis, Ulcerative

Korea, Republic of
Eisai Korea Inc.

Recruiting

A Post Marketing Surveillance Study of Equfina Tablet 50 Milligram (mg)

Parkinson Disease

Korea, Republic of
Eisai Korea Inc.

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of Perampanel Monotherapy in Untreated Participants With Focal Onset Seizures With or Without Focal to Bilateral Tonic-clonic Seizures

Epilepsy

Korea, Republic of
Eisai Korea Inc.

Completed

A Study to Evaluate the Efficacy and Safety of Safinamide Mesilate as Add-on Therapy to Levodopa in Parkinson's Disease Participants With Motor Fluctuation in South Korea

Parkinson Disease

Korea, Republic of
Eisai Korea Inc.

Completed

The Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon Gene Polymorphisms to Donepezil in Alzheimer's Disease

Alzheimer's Disease

Korea, Republic of

3

Subscribe